NICOLE BAUKNECHT: Open Payments
NPI 1255758579 · NORTHBROOK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$924 in 49 payments from 9 companies in 2025. Trend: 2023 $346 · 2024 $762 · 2025 $924
Food & beverage: $924
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 18 | $266 |
| ABBVIE INC. | 10 | $244 |
| GENZYME CORPORATION | 10 | $157 |
| Medtronic, Inc. | 3 | $83 |
| AstraZeneca Pharmaceuticals LP | 2 | $53 |
| Lilly USA, LLC | 2 | $47 |
| Stryker Corporation | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Phadia US Inc. | 1 | $14 |
Products named: NUCALA, DUPIXENT, QULIPTA, BOTOX, PROPEL, TEZSPIRE, XPRESS LOPROFILE, ZEPBOUND.
Industry payments across IL — which companies pay providers there.
